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INTRODUCTION

RESULTS

CONCLUSIONS

High-grade gliomas (HGG) are aggressive
brain cancers that can progress during
chemoradiation (CRT), resulting in
underdosing of the tumor. While adaptive
radiotherapy (RT) can react to tumor changes,
spatially-resolved predictions of progression
could enable anticipatory modifications of RT
and improve tumor control.

• The 2 most parsimonious models described the
• Low percent errors in tumor volume were observed
enhancing and non-enhancing disease with (3across both models
species) or without (2-species) vasculature
• High CCC values were observed for the 2-species
dynamics, each with a spatially varying proliferation
model
rate and the efficacy of RT coupled to perfusion

• We observed good agreement
on both the global (percent error
in tumor volume) and local
(CCC) levels
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We aim to create personalized
spatiotemporal forecasts of HGG response
to chemoradiation via a family of 60
mechanism-based mathematical models
calibrated using serial multi-parametric
magnetic resonance imaging (mpMRI).
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• This preliminary data
demonstrates the plausibility of
spatially predicting HGG
response to CRT
• Future modifications, such as the
inclusion of advanced perfusion
imaging, should further inform
spatiotemporal dynamics
• Accurate and reliable predictions
may eventually enable
anticipatory, adaptive
radiotherapy and improve
clinical outcomes
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